New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells

    Thumbnail
    Download
    Citations
    Scopus
    Web of Science
    Altmetric
    13
    13
    Author
    O'Brien, CM; Chy, HS; Zhou, Q; Blumenfeld, S; Lambshead, JW; Liu, X; Kie, J; Capaldo, BD; Chung, T-L; Adams, TE; ...
    Date
    2017-03-01
    Source Title
    Stem Cells
    Publisher
    WILEY
    University of Melbourne Author/s
    Lindeman, Geoffrey; Visvader, Jane; Capaldo, Bianca; Rossello, Fernando
    Affiliation
    Medical Biology (W.E.H.I.)
    Medicine and Radiology
    Clinical Pathology
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    O'Brien, C. M., Chy, H. S., Zhou, Q., Blumenfeld, S., Lambshead, J. W., Liu, X., Kie, J., Capaldo, B. D., Chung, T. -L., Adams, T. E., Tram, P., Bentley, J. D., McKinstry, W. J., Oliva, K., McMurrick, P. J., Wang, Y. -C., Rossello, F. J., Lindeman, G. J., Chen, D. ,... Laslett, A. L. (2017). New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells. STEM CELLS, 35 (3), pp.626-640. https://doi.org/10.1002/stem.2558.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/258016
    DOI
    10.1002/stem.2558
    Abstract
    The study and application of human pluripotent stem cells (hPSCs) will be enhanced by the availability of well-characterized monoclonal antibodies (mAbs) detecting cell-surface epitopes. Here, we report generation of seven new mAbs that detect cell surface proteins present on live and fixed human ES cells (hESCs) and human iPS cells (hiPSCs), confirming our previous prediction that these proteins were present on the cell surface of hPSCs. The mAbs all show a high correlation with POU5F1 (OCT4) expression and other hPSC surface markers (TRA-160 and SSEA-4) in hPSC cultures and detect rare OCT4 positive cells in differentiated cell cultures. These mAbs are immunoreactive to cell surface protein epitopes on both primed and naive state hPSCs, providing useful research tools to investigate the cellular mechanisms underlying human pluripotency and states of cellular reprogramming. In addition, we report that subsets of the seven new mAbs are also immunoreactive to human bone marrow-derived mesenchymal stem cells (MSCs), normal human breast subsets and both normal and tumorigenic colorectal cell populations. The mAbs reported here should accelerate the investigation of the nature of pluripotency, and enable development of robust cell separation and tracing technologies to enrich or deplete for hPSCs and other human stem and somatic cell types. Stem Cells 2017;35:626-640.

    Export Reference in RIS Format     

    Collections